SCHEMBL6388296

SCHEMBL6388296

CCCCn1c(=O)[nH]c2cccc(S(=O)(=O)O)c2c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.46
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.41
MPO P05164 2/20 0.41
RAB9A P51151 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
PDE4A P27815 1/20 0.40
ADORA2A P29274 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
CYP1A2 P05177 1/20 0.39
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395227 0.92 ADORA2B (0.44) ADORA2BALDH1A1HPGDKDM4EHSD17B10
SCHEMBL6388376 0.87 CYP1A2 (0.52) ADORA2BALDH1A1HPGDKDM4EADORA3
SCHEMBL6386965 0.81 FEN1 (0.42) ADORA2BALDH1A1HSD17B10ADORA2ATSHR
SCHEMBL6392142 0.80 ADORA2B (0.48) ADORA2BALDH1A1HPGDKDM4EHSD17B10
SCHEMBL6392681 0.80 TSHR (0.44) ADORA2BALDH1A1HPGDGAAMAPK1
SCHEMBL6393905 0.80 ADORA2B (0.49) ADORA2BADORA3ADORA2ALMNA
SCHEMBL6389576 0.75 CNR1 (0.42) ADORA2BALDH1A1GAAPDE4AADORA2A
SCHEMBL6394915 0.75 FEN1 (0.42) ADORA2BADORA3ADORA2AMAPTCYP1A2
SCHEMBL6387006 0.74 POLB (0.48) ALDH1A1LMNAMCOLN3L3MBTL1
SCHEMBL14560539 0.73 ALDH1A1 (0.73) ADORA2BALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1237119-C Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2006-01-18 CN disclosed
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 US disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 ADORA2B 2241/4885ALDH1A1 667/4885HPGD 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.